comparemela.com
  1. Home
  2. Live Updates
  3. Prnewswire Glycopath - Breaking News

Latest Breaking News On - Prnewswire glycopath - Page 1 : comparemela.com

GlycoPath Inc Applies Proprietary Technology to Lyme Disease to Distinguish Among Disease States and Track Treatment Response

/PRNewswire/ GlycoPath s proprietary GlycoTyper™ immunoaffinity technology was used to distinguish between Lyme disease infection states and track treatment.

United statesDrexel universityBenjamin haslund gourleyPrnewswire glycopathMary ann comunaleDrexel university college of medicineNational cancer instituteGlycopath incDrexel university college

GlycoPath Inc Receives Prestigious Grant from the National Cancer Institute

/PRNewswire/ GlycoPath has received an STTR grant from the National Cancer Institute to utilize their patent-pending GlycoTyper™ technology for the.

United statesPrnewswire glycopathNational cancer instituteGlycopath inc

GlycoPath Inc Receives Prestigious Grant from the National Cancer Institute

/PRNewswire/ GlycoPath has received an STTR grant from the National Cancer Institute to utilize their patent-pending GlycoTyper™ technology for the.

United statesPrnewswire glycopathNational cancer instituteGlycopath inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.